Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Adrenergic-pathway gene variants influence beta-blocker-related outcomes after acute coronary syndrome in a race-specific manner.

Cresci S, Dorn GW 2nd, Jones PG, Beitelshees AL, Li AY, Lenzini PA, Province MA, Spertus JA, Lanfear DE.

J Am Coll Cardiol. 2012 Sep 4;60(10):898-907. doi: 10.1016/j.jacc.2012.02.051. Epub 2012 Jun 13.

2.

Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.

Lanfear DE, Jones PG, Marsh S, Cresci S, McLeod HL, Spertus JA.

JAMA. 2005 Sep 28;294(12):1526-33.

PMID:
16189366
3.

Clinical and genetic modifiers of long-term survival in heart failure.

Cresci S, Kelly RJ, Cappola TP, Diwan A, Dries D, Kardia SL, Dorn GW 2nd.

J Am Coll Cardiol. 2009 Jul 28;54(5):432-44. doi: 10.1016/j.jacc.2009.05.009.

4.

Interaction between PPARA genotype and beta-blocker treatment influences clinical outcomes following acute coronary syndromes.

Cresci S, Jones PG, Sucharov CC, Marsh S, Lanfear DE, Garsa A, Courtois M, Weinheimer CJ, Wu J, Province MA, Kelly DP, McLeod HL, Spertus JA.

Pharmacogenomics. 2008 Oct;9(10):1403-17. doi: 10.2217/14622416.9.10.1403.

5.

Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol.

Sehnert AJ, Daniels SE, Elashoff M, Wingrove JA, Burrow CR, Horne B, Muhlestein JB, Donahue M, Liggett SB, Anderson JL, Kraus WE.

J Am Coll Cardiol. 2008 Aug 19;52(8):644-51. doi: 10.1016/j.jacc.2008.05.022. Epub 2008 Jun 23.

6.

GRK5 Gln41Leu polymorphism is not associated with sensitivity to beta(1)-adrenergic blockade in humans.

Kurnik D, Cunningham AJ, Sofowora GG, Kohli U, Li C, Friedman EA, Muszkat M, Menon UB, Wood AJ, Stein CM.

Pharmacogenomics. 2009 Oct;10(10):1581-7. doi: 10.2217/pgs.09.92.

7.

A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure.

Liggett SB, Cresci S, Kelly RJ, Syed FM, Matkovich SJ, Hahn HS, Diwan A, Martini JS, Sparks L, Parekh RR, Spertus JA, Koch WJ, Kardia SL, Dorn GW 2nd.

Nat Med. 2008 May;14(5):510-7. doi: 10.1038/nm1750. Epub 2008 Apr 20.

8.

beta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in hypertension.

Pacanowski MA, Gong Y, Cooper-Dehoff RM, Schork NJ, Shriver MD, Langaee TY, Pepine CJ, Johnson JA; INVEST Investigators.

Clin Pharmacol Ther. 2008 Dec;84(6):715-21. doi: 10.1038/clpt.2008.139. Epub 2008 Jul 9.

9.

Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.

Lobmeyer MT, Gong Y, Terra SG, Beitelshees AL, Langaee TY, Pauly DF, Schofield RS, Hamilton KK, Herbert Patterson J, Adams KF Jr, Hill JA, Aranda JM Jr, Johnson JA.

Pharmacogenet Genomics. 2007 Apr;17(4):277-82.

PMID:
17496726
10.

Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study.

Ortega VE, Hawkins GA, Moore WC, Hastie AT, Ampleford EJ, Busse WW, Castro M, Chardon D, Erzurum SC, Israel E, Montealegre F, Wenzel SE, Peters SP, Meyers DA, Bleecker ER.

Lancet Respir Med. 2014 Mar;2(3):204-13. doi: 10.1016/S2213-2600(13)70289-3. Epub 2014 Jan 27.

11.

Effect of specific ADRB1/ADRB2/AGT genotype combinations on the association between survival and carvedilol treatment in chronic heart failure: a substudy of the ECHOS trial.

Petersen M, Andersen JT, Jimenez-Solem E, Broedbaek K, Afzal S, Nyegaard M, Børglum AD, Stender S, Torp-Pedersen C, Køber L, Poulsen HE.

Pharmacogenet Genomics. 2012 Oct;22(10):709-15. doi: 10.1097/FPC.0b013e3283540286.

PMID:
22760495
12.

APOL1 Genotype, Kidney and Cardiovascular Disease, and Death in Older Adults.

Mukamal KJ, Tremaglio J, Friedman DJ, Ix JH, Kuller LH, Tracy RP, Pollak MR.

Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):398-403. doi: 10.1161/ATVBAHA.115.305970. Epub 2015 Dec 3.

PMID:
26634651
13.

Beta2-adrenergic receptor genotype and survival after acute coronary syndrome.

Jackson CM, Lipworth BJ.

JAMA. 2006 Feb 15;295(7):757; author reply 757-8. No abstract available.

PMID:
16478896
14.

Beta2-adrenergic receptor genotype and survival after acute coronary syndrome.

Snyder EM, Johnson BD.

JAMA. 2006 Feb 15;295(7):756-7; author reply 757-8. No abstract available.

PMID:
16478895
15.

β2-Adrenergic receptor promoter haplotype influences the severity of acute viral respiratory tract infection during infancy: a prospective cohort study.

Wu P, Larkin EK, Reiss SS, Carroll KN, Summar ML, Minton PA, Woodward KB, Liu Z, Islam JY, Hartert TV, Moore PE.

BMC Med Genet. 2015 Sep 14;16:82. doi: 10.1186/s12881-015-0229-3.

16.

Investigation of 95 variants identified in a genome-wide study for association with mortality after acute coronary syndrome.

Morgan TM, House JA, Cresci S, Jones P, Allayee H, Hazen SL, Patel Y, Patel RS, Eapen DJ, Waddy SP, Quyyumi AA, Kleber ME, März W, Winkelmann BR, Boehm BO, Krumholz HM, Spertus JA.

BMC Med Genet. 2011 Sep 29;12:127. doi: 10.1186/1471-2350-12-127.

17.

Racial differences in the medical treatment of elderly Medicare patients with acute myocardial infarction.

Allison JJ, Kiefe CI, Centor RM, Box JB, Farmer RM.

J Gen Intern Med. 1996 Dec;11(12):736-43.

PMID:
9016420
18.

Effects of GRK5 and ADRB1 polymorphisms influence on systolic heart failure.

Kang S, Hong X, Ruan CW, Yu P, Yu SS, Chen M, Zhang DF, Fan HM, Liu ZM.

J Transl Med. 2015 Feb 1;13:44. doi: 10.1186/s12967-015-0402-7.

19.
20.

Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry.

Shaw LJ, Shaw RE, Merz CN, Brindis RG, Klein LW, Nallamothu B, Douglas PS, Krone RJ, McKay CR, Block PC, Hewitt K, Weintraub WS, Peterson ED; American College of Cardiology-National Cardiovascular Data Registry Investigators.

Circulation. 2008 Apr 8;117(14):1787-801. doi: 10.1161/CIRCULATIONAHA.107.726562. Epub 2008 Mar 31.

Items per page

Supplemental Content

Write to the Help Desk